Updates are available Correction dated 2024-04-08
Click to view Correction: https://doi.org/10.1038/s41467-024-47421-2
-
Authors
Ahani, Bahar
Tuffy, Kevin M.
Aksyuk, Anastasia A. https://orcid.org/0000-0001-9778-3491
Wilkins, Deidre
Abram, Michael E. https://orcid.org/0000-0002-6505-7281
Dagan, Ron https://orcid.org/0000-0002-8888-1046
Domachowske, Joseph B.
Guest, Johnathan D. https://orcid.org/0000-0003-1521-5242
Ji, Hong
Kushnir, Anna
Leach, Amanda
Madhi, Shabir A. https://orcid.org/0000-0002-7629-0636
Mankad, Vaishali S.
Simões, Eric A. F.
Sparklin, Benjamin https://orcid.org/0000-0002-5547-185X
Speer, Scott D.
Stanley, Ann Marie https://orcid.org/0000-0002-0588-8681
Tabor, David E.
Hamrén, Ulrika Wählby
Kelly, Elizabeth J. https://orcid.org/0000-0002-6988-8576
Villafana, Tonya
-
Funding
Funding for this research was provided by:
AstraZeneca
Sanofi
- License Information
-
More Information
Article History
Received: 3 February 2023
Accepted: 10 July 2023
First Online: 19 July 2023
Change Date: 8 April 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-024-47421-2
Competing interests
: R.D. has received grants from AstraZeneca, Merck, and Pfizer; consulting fees from Merck and Pfizer; and honoraria from GSK, Merck, Pfizer, and Sanofi Pasteur. J.B.D. has received consulting fees from Sanofi; payment or honoraria from Sanofi; and has participated in data safety monitoring boards or advisory boards for AstraZeneca. S.A.M. has received grants or contracts from BMGF, GSK, Minervax, Pfizer, and the South African Medical Research Council; payments or honoraria from BMGF; and has participated in data safety monitoring boards or advisory boards for CAPRISA and PATH. E.A.S. has received grants or contracts from AstraZeneca, Johnson and Johnson, Merck, Pfizer, and Roche; consulting fees from Adiago Therapeutics, Cidara Therapeutics, Merck, Nuance Pharmaceuticals, Pfizer, and Sanofi; payment or honoraria from AstraZeneca and Pfizer; support for meeting attendance and/or travel from AstraZeneca; and has participated in data safety monitoring boards or advisory boards for Abbvie, Bill and Melinda Gates Foundation, and GSK. B.A., K.M.T., A.A.A., D.W., J.D.G., H.J., B.S., A.K., A.M.S., V.S.M., A.L., U.W.H., E.J.K., and T.V. are current employees of AstraZeneca and may hold stock or stock options. S.D.S., D.E.T., and M.E.A. are former employees of AstraZeneca.
